In this article, we describe the inhibitory properties of a series of potent phosphonate-based MMP inhibitors against the cytosolic off-target isoforms CA I and II and the three trans-membrane (two of which are cancer-related) isoforms CA IX, XII and XIV. Here, CA9 is linked to cancer.